Literature DB >> 6278224

Receptor for 1,25-dihydroxyvitamin D3 in GH3 pituitary cells.

M R Haussler, S C Manolagas, L J Deftos.   

Abstract

Cytosol prepared in 0.3 M KCl from pituitary GH3 cells, but not from AtT-20 cells contains a receptor-like macromolecule that binds 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) with specificity and high affinity (Kd = 2.9 x 10(-10) M). The GH3 cytosolic binding component sediments at 3.3 S in high-salt sucrose gradients and adsorbs to DNA-cellulose; its elution profile from DNA-cellulose and other biochemical properties are indistinguishable from those of classical 1,25(OH)2D3 hormone receptors. The presence of the 1,25(OH)2D3 receptor in pituitary cells which secrete primarily growth hormone and prolactin (GH3), but not in a line which secretes the 31,000-dalton ACTH precursor and its derived peptides (AtT-20), suggests that 1,25(OH)2D3 may play a regulatory role in specific pituitary cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278224     DOI: 10.1016/0022-4731(82)90138-8

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  9 in total

1.  TSH levels are associated with vitamin D status and seasonality in an adult population of euthyroid adults.

Authors:  I Barchetta; M G Baroni; F Leonetti; M De Bernardinis; L Bertoccini; M Fontana; E Mazzei; A Fraioli; M G Cavallo
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

Review 2.  Vitamin D--soltriol the heliogenic steroid hormone: somatotrophic activator and modulator. Discoveries from histochemical studies lead to new concepts.

Authors:  W E Stumpf
Journal:  Histochemistry       Date:  1988

3.  Effects of vitamin D3 metabolites on thyrotropin secretion from rat pituitary cells in culture.

Authors:  K Törnquist; L Forss; C Lamberg-Allardt
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

4.  The response of creatine kinase specific activity in rat pituitary to estrogenic compounds and vitamin d less-calcemic analogs.

Authors:  D Somjen; N Mirsky; S Tamir; J Vaya; G H Posner; A M Kaye
Journal:  Int J Cell Biol       Date:  2009-09-10

5.  Culture requirements for optimal expression of 1 alpha,25-dihydroxyvitamin D3-enhanced thyrotropin secretion.

Authors:  M C d'Emden; J D Wark
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

6.  Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.

Authors:  D Verbeelen; L Vanhaelst; M Fuss; A C Van Steirteghem
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

7.  Vitamin D sites of action in the pituitary studied by combined autoradiography-immunohistochemistry.

Authors:  W E Stumpf; M Sar; L P O'Brien
Journal:  Histochemistry       Date:  1987

8.  Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in basal cells of epidermis of neonatal and adult mice.

Authors:  J Merke; D Schwittay; G Fürstenberger; M Gross; F Marks; E Ritz
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

9.  Serum vitamin D metabolites do not change in response to intravenous injection of thyrotropin releasing hormone (TRH) and growth hormone releasing factor (GHRF 1-44) in children.

Authors:  R Rosskamp; S Issa; W Burmeister
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.